STVN peer analysis
Stevanato (STVN) against its competitors: price, today's move, 1-year return and market value side by side.
STVN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATR AptarGroup | $142.78 | -0.93% | 22.29% | $9.02B |
| AVTR Avantor | $15.72 | 1.00% | 37.39% | $10.71B |
| AXSM Axsome Therapeutics | $149.07 | 5.75% | 7.36% | $7.78B |
| BLCO Bausch + Lomb | $21.22 | -0.70% | 32.87% | $7.59B |
| BTSG BrightSpring Health | $72.68 | 0.26% | 116.62% | $14.47B |
| CHE Chemed | $550.55 | 1.11% | 24.37% | $7.06B |
| MMSI Merit Medical | $88.09 | 0.32% | -0.33% | $5.27B |
| TFX Teleflex | $156.15 | 0.55% | 43.49% | $6.56B |
| STVN Stevanato | $13.83 | 2.22% | -42.85% | $3.79B |
- STVN's peers: ATR (AptarGroup), AVTR (Avantor), AXSM (Axsome Therapeutics), BLCO (Bausch + Lomb), BTSG (BrightSpring Health), CHE (Chemed), MMSI (Merit Medical), TFX (Teleflex).
Updated 2026-11-12 02:51 UTC